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Poorly Compressible Leg Arteries:
A Specific Presentation of
Peripheral Artery Disease
We commend Arain et al. (1) for their elegant study comparing the
survival of patients with peripheral artery disease (PAD) and
poorly compressible arteries (PCA) who were referred to their
vascular laboratory. They supported previous findings, in both the
general population and the clinical setting, that individuals with a
very high ankle-brachial index (ABI) are at increased risk of
mortality (2,3). They also suggested that patients with PCA have
a poorer prognosis compared with patients with PAD. This
assertion may be due to some misinterpretations and residual
confounding factors.
Actually, their PAD group included patients with mild disease
who had an ABI at rest 0.90 but 0.90 after 1 minute of
xercise. Also, they calculated ABI by taking the lowest ankle
rtery pressure, so those who had only 1 diseased ankle artery were
ncluded in the PAD group, whereas to be included in the PCA
roup, patients should have both ankle arteries stiffened. Alto-
ether, the authors were more sensitive to include mild PAD, but
ery specific to define PCA. The authors redid the analyses taking
he highest pressure between ankle arteries, decreasing the hazard
atio for mortality in case of PCA versus PAD, at the limits of
tatistical significance. It is unclear how patients with PAD in one
imb but PCA in the other limb were classified. This situation has
een observed in 10% of diabetic patients who were referred to our
ascular laboratory (3).
In their multivariate analysis, the authors might have missed 2
esidual confounding factors: First, the models were adjusted to
edications at baseline, but patients with PAD might have
eceived more preventive treatments after the diagnosis, including
tatins, antiplatelet drugs, and angiotensin-converting enzyme
nhibitors, compared with patients with PCA, because at that time
he increased risk of the latter group was unknown. Of note, the
se of angiotensin-converting enzyme inhibitors has not been
ncluded in the models. A recent analysis of the National Healthand Nutrition Examination Survey cohort showed that patients
with an ABI 0.90 who took at least 2 of the 3 drug groups
mentioned would have an improved prognosis (4). Second, beyond
adjustments for age and diabetes—2 major risk factors for PCA—
the duration of diabetes per se is an independent factor associated
with this condition (3,5), a factor not studied by the authors.
Finally, the authors show that the coexistence of PAD as
revealed by Doppler is an independent predictor of mortality in
patients with PCA, in line with our study (3). Whether patients
with isolated PCA remained at increased risk of mortality com-
pared with the PAD group has not been addressed. We found that
diabetic patients with PCA without concomitant PAD had a
survival equivalent to that of patients with normal ABI (3). In their
series, a substantial proportion of patients with PCA had critical
limb ischemia, twice as frequent as in the PAD group. We believe
that the higher risk reported in patients with PCA versus PAD is
related to a high proportion of concomitant severe PAD in the
PCA group, compared with less severe disease in the PAD group.
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Reply
We thank Dr. Aboyans and colleagues for their interest in our
study (1). They remark that our observation of a higher risk of
death in patients with poorly compressible arteries (PCA) than in
patients with peripheral arterial disease (PAD) may have been due
to inclusion of patients with an abnormal post-exercise ankle-
brachial index (ABI) and use of the lower ankle pressure to
calculate the ABI. An ABI 0.9 after exercise is an established
vascular laboratory criterion for PAD, and therefore such patients
were included in our analyses. We used the lower of the 2 ankle
pressures to calculate the ABI in each leg because such an approach
identifies a greater number of patients at risk for adverse cardio-
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(2,3). Our inferences remained unchanged when we used the
higher ankle pressure in calculating the ABI (1). Assigning
patients who had PCA in one leg and a low ABI in the other leg
to the PCA group is unlikely to have influenced our results because
only 2.2% of the patients had both PCA and PAD.
Second, Dr. Aboyans and colleagues raise the issue of residual
confounding. We performed a rigorous adjustment for potential
confounders, including cardiovascular risk factors (age, sex, systolic
blood pressure, hypertension, smoking, body mass index, and
diabetes), comorbidities (coronary heart disease, cerebrovascular
disease, congestive heart failure, chronic kidney disease, malig-
nancy, and chronic obstructive pulmonary disease), medication use
(statins and aspirin), and the presence of critical limb ischemia.
he hypothesis that patients with PCA may not have been
reated as aggressively as patients with PAD is interesting and
ill need to be addressed in future studies. With regard to the
uration of diabetes, this is difficult to ascertain accurately, even
n prospective studies, given the often long pre-symptomatic
tage for this disease.
Finally, Dr. Aboyans and colleagues remark that we did not
ddress whether patients with isolated PCA remained at increased
isk of death compared with the PAD group. In fact, this analysis
as reported in our study (1). The risk of death in patients with
CA but normal Doppler waveforms was higher than in those
ith normal ABI (fully adjusted hazard ratio: 1.4; 95% confidence
nterval: 1.2 to 1.6) and similar in those with PAD (fully adjustedhazard ratio: 0.9; 95 confidence interval: 0.8 to 1.1). However, the
presence of abnormal Doppler waveforms in patients with PCA
was associated with a significant increment in the risk of death,
suggesting that the presence of atherosclerosis adds to the risk
because of medial arterial calcification.
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